医学
肺癌
疾病
重症监护医学
肿瘤科
内科学
癌症
作者
Alesha Thai,Benjamin Solomon,Lecia V. Sequist,Justin F. Gainor,Rebecca S. Heist
出处
期刊:The Lancet
[Elsevier]
日期:2021-07-21
卷期号:398 (10299): 535-554
被引量:1291
标识
DOI:10.1016/s0140-6736(21)00312-3
摘要
Summary
Lung cancer is one of the most frequently diagnosed cancers and the leading cause of cancer-related deaths worldwide with an estimated 2 million new cases and 1·76 million deaths per year. Substantial improvements in our understanding of disease biology, application of predictive biomarkers, and refinements in treatment have led to remarkable progress in the past two decades and transformed outcomes for many patients. This seminar provides an overview of advances in the screening, diagnosis, and treatment of non-small-cell lung cancer and small-cell lung cancer, with a particular focus on targeted therapies and immune checkpoint inhibitors.
科研通智能强力驱动
Strongly Powered by AbleSci AI